Merck 2008 Annual Report Download - page 63
Download and view the complete annual report
Please find page 63 of the 2008 Merck annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53 -
54 -
55 -
56 -
57 -
58 -
59 -
60 -
61 -
62 -
63 -
64 -
65 -
66 -
67 -
68 -
69 -
70 -
71 -
72 -
73 -
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
 |
 |
58 | Merck Annual Report 2008
Laboratory Business
Growth in Asia and Latin America
In 2008, total revenues of Laboratory Business decreased slightly by 1.6%. On a currency-
adjusted basis, total revenues increased by 2.5%. We are represented by our own local
companies in 42 countries worldwide with a broad range of laboratory chemicals. We
were satisfied with growth in Asia, which reached 6.5% despite strong negative currency
effects, and in Latin America, where sales rose by 7.4%. Sales in the European market
remained stable, while a decline was recorded in the comparatively smaller market of
North America.
Innovative rapid food tests
Our microbiology business achieved sustainable growth in 2008. Rapid microbiology
tests have become a special highlight of our portfolio. They are used to detect harmful
and pathogenic microorganisms in foods, such as salmonella and coli bacteria. The
business for food and environmental tests with the newly launched Spectroquant®
Pharo spectrophotometers got off to a good start. They are used to perform tests of the
Spectroquant® range rapidly, precisely and efficiently. With our U.S.-based coopera-
tion partner Rules-Based Medicine Inc., we further expanded the bioscience business
with bead-based assays for biomarker detection in pharmaceutical research.
New products for chromatography
By acquiring the Swedish company SeQuant we rounded off the chromatography port-
folio. SeQuant specializes in the development of products for chromatography, namely
the separation of polar chemical compounds. The focus is on innovative ZIC-HILIC®
technology. This product line ideally complements our existing portfolio in HPLC
(high-performance liquid chromatography). In 2008, ZIC-HILIC® products were also
used to test for melamine contamination in formula, as recommended by the U.S. Food
and Drug Administration (FDA).
Life Science Solutions
Emprove® premium brand portfolio expanded
Life Science Solutions achieved growth of 7.9%. On a currency-adjusted basis, the
increase amounted to 10%. Sales rose by 16% in the important market of North America
and by 19% in Latin America. The business with pharmaceutical raw materials gener-
ated particularly strong growth. Emprove®, Merck’s premium brand of pharmaceutical
raw materials, generated double-digit growth and was expanded. This brand stands
for comprehensive service and excellent quality. The portfolio now comprises three
application areas: Emprove® exp for use as a pharmaceutical excipient, Emprove® bio
for use in biopharmaceutical production and Emprove® api for use as an active
pharmaceutical ingredient.
www.merck-chemicals.com/
food-analytics
Rapid food tests are easy
to use.
www.merck-chemicals.com/
life-science-research